Court Validates Cumberland’s Patent for Overdose Drug Acetadote in Dispute with Mylan

The U.S. Court of Appeals for the Federal Circuit affirmed Cumberland Pharmaceuticals’ patent for its second-generation version of Acetadote, barring Mylan from marketing a generic of the overdose therapy.
Source: Drug Industry Daily